"Designing Acute Stroke Therapy for a New Decade"

STAIR VII Sponsors

Arbor Vita Corporation

Bayer HealthCare Pharmaceuticals BioClinica, Inc.

BrainsGate Ltd.

Celgene Cellular Therapeutics

CoAxia, Inc.

Concentric Medical, Inc.

Covidien ev3 Inc.

EVER Neuro Pharma GmbH

Ferrer Therapeutics, Inc.

Fraunhofer Institute

Genentech, Inc.

GlaxoSmithKline

Lundbeck, Inc.

Micrus Endovascular

MindFrame, Inc.

Mitsubishi Tanabe Pharma Development, Inc. Neurointerventional Therapeutics, Inc.

Penumbra, Inc.

Pfizer Global R&D

PhotoThera, Inc.

Rapid Medical, Inc.

Sygnis Bioscience GmbH

Thrombolytic Science International W. L. Gore & Associates, Inc.

The information contained in this website reflects opinions of STAIR participants regarding the process of conducting research and development into existing, new and prospective drugs and devices for the treatment of stroke. The information is not intended to be a substitute for rigorous independent testing and development of individual compounds and devices by research sponsors, nor should the information and opinions be construed as official government regulations or official interpretations of government regulations. All government regulations and their applications to specific research studies and clinical trials are subject to individual deliberations between study sponsors and government agencies. The information contained in this website is not intended to be a substitute for sound medical advice, clinical judgment or informed treatment decisions.

STAIR® is a Registered Trademark of The Stroke Group.   

© 2020 The Stroke Group